US · PI Dr. A. Reyes · activated
Patients
3
Active
2
Serious AEs
0
Open QA
1
Aged queries
0
Luna users
2
Studies & contracts
GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II · study active · contract executed · 184000 USD
Safety — 1 AEs, 0 serious
No serious adverse events.
QA findings (1 open)
open
major
DOSE MODIFICATION ERROR: Dose held longer than protocol-permitted 6 weeks.
Visits & payments
💳 23500 USD
pending_review
due 2026-09-17
☾ Luna participants
Maya Okonkwo
GAL001-001
granted
Jonah Reyes
GAL001-002
granted